Multi-site generic drug and biosimilar manufacturer with 290+ products
Amneal manufactures generics, injectables, biosimilars, and specialty drugs across multiple facilities. The tech stack is pharmaceutical-operations-native (Veeva, LIMS, SAP S/4HANA, Manhattan WMS, Rockwell Automation SCADA) with heavy analytical instrumentation (HPLC, UPLC, ICP-MS, FT-IR). Current hiring is manufacturing-heavy (129 open roles) with a focus on process validation, equipment qualification, and cross-site technology transfer—typical of a multi-site operator scaling compliance and operational consistency.
Amneal Pharmaceuticals manufactures and distributes generic drugs, complex injectables, biosimilars, and specialty medicines across the US and India. The company operates as a public manufacturer (NASDAQ: AMRX) with a portfolio of more than 290 products and a workforce of 5,001–10,000 employees. Operations span process development, manufacturing, quality assurance, and distribution, supported by enterprise systems (SAP S/4HANA, Veeva, LIMS, supply-chain tools) and analytical labs. The active project list reflects a mature multi-site operation focused on regulatory compliance, equipment validation, and technology transfer across facilities.
Amneal uses Veeva (regulatory/CRM), SAP S/4HANA (ERP), LIMS (lab management), Manhattan WMS (supply chain), Rockwell Automation (manufacturing automation), and analytical instruments (HPLC, UPLC, ICP-MS, FT-IR). Currently adopting SAP S/4HANA.
Amneal is headquartered in Bridgewater, New Jersey and operates manufacturing and hiring across the United States and India.
Other companies in the same industry, closest in size